We're offering Lifetime and discounted 3-year Subscriptions this month only. Details here

Message Boards | Biotechnology : Momenta Pharmaceuticals Inc. -- Ignore and Intra-subject Search unavailable to you. Want to Upgrade?
Posts: 2106 | Member SubjectMarks: 63 | No Bans | Board Shortcut:

Add SubjectMark | Show Original Post | Show Chart | Poster Summary | Email This Page

Moderated By: michael_f_murphy -- (Not Moderated) -- Started: 3/11/2004 9:35:36 PM  Revision History

Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplySubjectFromRecsDate
2106MNTA: Upgraded - JAGNote by Oppenheimer & Co. Inc. 8:04 am ET 11/19/2009- JAG MArthur Radley-11/19/2009 12:17:45 PM
2105Thanks, Cary (eom)DewDiligence_on_SI-11/18/2009 06:51:09 PM
2104http://www.fiercebiotech.com/special-reports/radar-novembers-stocks-watch-page-2Arthur Radley-11/18/2009 04:58:20 PM
2103Teva amends Copaxone suit against MNTA/NVS: httDewDiligence_on_SI-11/10/2009 03:56:39 AM
2102MNTA ‘ReadMeFirst’ updated: <i>3Q09 financial rDewDiligence_on_SI-11/07/2009 06:49:07 PM
2101seekingalph: Momenta Pharmaceuticals, Inc. (MNTA) mopgcw-11/07/2009 09:46:38 AM
2100The Lovenox plot may have thickened: http://investorshub.advfn.com/boards/reaDewDiligence_on_SI111/03/2009 08:30:04 PM
2099Good point. I can't think of one, but sad to say I didn't take advantage of it.tom pope-10/16/2009 09:35:02 PM
2098Options - another month, another 6-7%. Not quite the 10% monthly that it yieldeRocky9-10/16/2009 03:48:01 PM
2097Can't say that I disagree. 5 years seems to me to be fair, and as stated, does Biotech Jim-10/15/2009 07:16:39 PM
2096http://finance.yahoo.com/news/New-England-Journal-of-bw-2632366544.html?x=0&.v=1Arthur Radley-10/15/2009 04:46:58 PM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):


Copyright © 2009 TZ Holdings LLC. All rights reserved.